04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 7:37 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024 3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:40 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/29/2024 7:23 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:44 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:53 PM | Eagle Pharmaceuticals (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024 7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by) Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024 8:15 AM | Eagle Pharmaceuticals (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024 4:09 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 1:04 PM | Eagle Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:00 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:01 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 6:00 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023 3:34 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 4:23 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/09/2023 6:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:39 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 4:41 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 7:49 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 6:10 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 4:07 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:48 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 6:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 5:55 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:06 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
07/24/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 5:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 7:43 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 7:23 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/18/2023 4:22 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 7:34 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 11:43 AM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023 5:58 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2023 6:16 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |